Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

I think you are mistaken. The company has failed miserably at executing on communicated timelines and this destroys the credibility of management. However, this company isn’t big enough to have sell-side coverage and instead caters to a fluid and uneducated OTC base for the most part.

The company is presently re-building credibility, little by little. Approvals are evident or the FDA wouldn’t have moved forward with pre-approval inspections.

The real questions are how will pricing compare to non-ADT, will the premium demanded equate to what the market is willing to pay (as of today the market wants cheap regardless of ADT), will ELTP parter or go alone and whether any of this will amount to real sales.

Signs point that the pendulum is swinging towards yes, despite poor management performance; however, there are some critical decisions to be made in near-term that can swing the pendulum back the other direction.

Also, will be interesting to see what first Sungen product will be and when that ANDA application will take place. Another bonus.